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Brucella melitensis Invades Murine Erythrocytes during Infection
Marie-Alice Vitry,a Delphine Hanot Mambres,a Michaël Deghelt,a Katrin Hack,a Arnaud Machelart,a Frédéric Lhomme,b
Jean-Marie Vanderwinden,c Marjorie Vermeersch,b Carl De Trez,d David Pérez-Morga,a,b Jean-Jacques Letesson,a Eric Muraillea,e
Unité de Recherche en Biologie des Microorganismes, Laboratoire d’Immunologie et de Microbiologie, NARILIS, University of Namur (UNamur), Namur, Belgiuma; Center
for Microscopy and Molecular Imaging, Université Libre de Bruxelles (ULB), Gosselies, Belgiumb; Laboratory of Neurophysiology, ULB, Campus Erasme, Brussels, Belgiumc;
Department of Molecular and Cellular Interactions, Vlaams Interuniversitair Instituut voor Biotechnologie, Vrije Universiteit Brussel, Brussels, Belgiumd; Laboratoire de
Parasitologie, Faculté de Médecine, ULB, Brussels, Belgiume
Brucella spp. are facultative intracellular Gram-negative coccobacilli responsible for brucellosis, a worldwide zoonosis. We ob-
served that Brucella melitensis is able to persist for several weeks in the blood of intraperitoneally infected mice and that trans-
ferred blood at any time point tested is able to induce infection in naive recipient mice. Bacterial persistence in the blood is dra-
matically impaired by specific antibodies induced following Brucella vaccination. In contrast to Bartonella, the type IV secretion
system and flagellar expression are not critically required for the persistence of Brucella in blood. ImageStream analysis of blood
cells showed that following a brief extracellular phase, Brucella is associated mainly with the erythrocytes. Examination by con-
focal microscopy and transmission electron microscopy formally demonstrated that B. melitensis is able to invade erythrocytes
in vivo. The bacteria do not seem to multiply in erythrocytes and are found free in the cytoplasm. Our results open up new areas
for investigation and should serve in the development of novel strategies for the treatment or prophylaxis of brucellosis. Inva-
sion of erythrocytes could potentially protect the bacterial cells from the host’s immune response and hamper antibiotic treat-
ment and suggests possible Brucella transmission by bloodsucking insects in nature.
Brucella is a facultative intracellular alphaproteobacterium thatcauses abortion and infertility in mammals and leads to a de-
bilitating febrile illness in humans. Although it is rarely fatal, hu-
man brucellosis can progress into a severe chronic disease if left
untreated (1, 2). Despite significant progress, the incidence of hu-
man brucellosis remains very high in areas of endemicity (3).
Complete eradication of Brucella would be impractical due to its
presence in a large range of wild mammals (4, 5). Moreover, an-
tibiotic treatment is costly, and patients frequently suffer from
relapse of the illness (6, 7). Vaccination actually remains the only
rational strategy to confer protection on populations living in
countries of endemicity. Unfortunately, there is currently no
available vaccine against human brucellosis, since all commercial
animal vaccines are based on live attenuated strains of Brucella (8)
that are still virulent in humans. Efforts to develop an effective
vaccine are impaired by our poor knowledge of the Brucella life
cycle in vivo and of the protective immune response induced by
infection. In particular, the mechanisms of early Brucella dissem-
ination in vivo remain largely unknown. A prominent character-
istic of brucellosis is its long incubation period. The current hy-
pothesis is that this period, corresponding to reduced activation of
innate immunity, opens an “immunological window” and gives
Brucella the chance to spread throughout the organism to estab-
lish a replication niche within phagocytic cells (9).
Bacteremia is one major characteristic of human brucellosis
(10) and is often associated with an increased risk of relapse (6,
11). Moreover, positive blood cultures are synonymous with sec-
ondary seeding and development of focal complications of the
disease. Bacteremia in mice infected by intraperitoneal injection,
the most frequent route of experimental infection, has been re-
ported in some studies (12, 13). However, to our knowledge, the
mechanism of Brucella persistence in the blood has never been
investigated. In this study, we monitored bacteremia in mice for
several weeks after the intraperitoneal inoculation of Brucella
melitensis strain 16M constitutively expressing the mCherry fluo-
rescent tracer. The location of B. melitensis in blood cells was an-
alyzed by ImageStream analysis and confocalmicroscopy.We also
investigated the impact of type IV secretion system and flagellum
deficiencies and of specific antibodies on the persistence of the
bacteria in blood.
Our results show that B. melitensis is able to persist for at least
2 weeks in the blood of infected mice after intraperitoneal inocu-
lation. The bacteria were first located extracellularly but were then
found mainly inside erythrocytes. To our knowledge, this partic-
ular niche of infection has never been described in brucellosis,
although it is relatively common in other bacteria of theAlphapro-
teobacteria phylum, such as Anaplasma (14) and Bartonella (15).
Circulating antibodies induced by vaccination drastically reduced
blood persistence of the bacteria following challenge.
MATERIALS AND METHODS
Ethics statement. The animal handling and procedures used in this study
complied with current European legislation (directive 86/609/EEC) and
the corresponding Belgian law, “Arrêté royal relatif à la protection des
animaux d’expérience du 6 Avril 2010 publié le 14 Mai 2010“ (Royal
Decree on the protection of experimental animals of 6 April 2010, pub-
lished on 14 May 2010). The complete protocol was reviewed and ap-
proved by the Animal Welfare Committee of the University of Namur
(permit number 05-558).
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Mice and reagents.MuMT/C57BL/6mice (16) and C57BL/6mice
transgenic for green fluorescent protein (GFP) under the control of the
ubiquitin C promoter (Ubi-GFP) (17) were purchased from The Jackson
Laboratory (Bar Harbor, ME). Wild-type C57BL/6 mice were purchased
fromHarlan (Bicester, UnitedKingdom) andwere used as the control. All
wild-type and deficient mice used in this study were bred in the Gosselies
animal facility of the Free University of Brussels (ULB) (Belgium).
B. melitensis strain 16M (biotype 1, ATCC 23456) was grown in a
biosafety level III laboratory facility. Cultures grown overnight under
shaking at 37°C in 2YTmedium (Luria-Bertani brothwith a double quan-
tity of yeast extract) to stationary phase were washed twice in phosphate-
buffered saline (PBS) (3,500  g, 10 min) as described previously (18).
When appropriate, we used B. melitensis strain 16M which stably ex-
presses the mCherry protein (mCherry-Br), a previously described rap-
idlymaturing variant of the red fluorescent proteinDsRed (19), under the
control of a strong Brucella species promoter named PsojA (20). The
construction of the mCherry-Br strain has been described previously in
detail (21). We also used the B. melitensis strain 16M producing GFP
(constructed by transferring the plasmid pBBR1-GFP-SOG [22] by mat-
ing), the virB mutant B. melitensis strain 16M (deficient for the type IV
secretion system [23]), and the fliC mutant B. melitensis strain 16M (de-
ficient for flagellin expression [24]).
Mouse infection. Mice were injected intraperitoneally (i.p.) with the
appropriate dose of B. melitensis in 500 l of PBS. Control animals were
injectedwith the same volume of PBS. The infectious doses were validated
by plating serial dilutions of inoculum. Mice were bled at selected time
points and sacrificed at the end of the experiment.
Blood transfer experiment.Micewere injected i.p. (500l) with fresh
blood from infected donor mice. Blood was diluted 20-fold in PBS before
immediate administration. Two weeks later, spleens were recovered in
PBS–0.1% Triton X-100. Serial dilutions in PBS were performed, fol-
lowed by plating on 2YT medium plates. The CFU counts were recorded
after 4 days of culture at 37°C.
Antibiotic treatment.Mice were injected i.p. with 4 104 CFU of B.
melitensis or with PBS. After resting for 3 weeks, both the immunized and
control mice were treated with antibiotics for 3 weeks. The treatment was
a combination of rifampin (12 mg/kg of body weight) and streptomycin
(450 mg/kg) (adapted from the method in reference 25) prepared fresh
daily and given in the drinking water. An additional treatment was given
i.p. and consisted of 5 injections of streptomycin (300mg/kg) throughout
the 3 weeks of oral treatment.
RAW cell infection. RAW cells grown in 6-well tissue culture plates
were inoculated with mCherry-Br at a multiplicity of infection (MOI) of
300 in 2 ml of cell culture medium (Dulbecco’s modified Eagle medium
[DMEM]–10% fetal bovine serum [FBS]). Cells were then centrifuged at
1,200 g for 10 min at 4°C and placed under 5% CO2 at 37°C. After 1 h,
the cells were washed two times in PBS and incubated further with cell
culturemedium supplemented with 50g/ml gentamicin until the end of
the infection time. After the indicated incubation time, the cells were
washed three times in PBS, collected, and centrifuged at 1,200 g for 10
min at 4°C. The cells were fixed in 300 l of PBS–4% paraformaldehyde
(PFA) for further ImageStream analysis.
Bacterial count. For bacterial counts in the blood, 70 l of blood was
collected from the tail into heparinized capillary tubes at the selected time
points and diluted in PBS–0.1% Triton X-100 (Sigma). Serial dilutions
were performed in PBS, followed by plating on 2YT medium plates. CFU
were counted after 4 days of culture at 37°C.
To separate the blood cells from the plasma, 140 l of blood was
collected anddiluted 4 times to allowbetter separation. Sampleswere then
centrifuged at 250  g for 10 min at room temperature (RT), and each
blood fraction was recovered. An additional centrifugation (8,000 g, 2
min, RT) was performed with the supernatant of samples from mice in-
fected with a low dose of bacteria (4  104 CFU). This was necessary to
concentrate the bacteria. The supernatant fraction was diluted in PBS
when necessary, while the pellet fraction was diluted in PBS–0.1% Triton
X-100. Each fractionwas then plated on 2YT, andCFUwere counted after
4 days of culture at 37°C.
Erythrocyte purification. Blood was collected from the tail into hep-
arinized capillary tubes at the selected time points, diluted in PBS, and
immediately filtered using Plasmodipur filters (EuroProxima), following
the recommendation of the manufacturer. Plasmodipur filters remove
leukocytes from blood (26, 27).
Cytofluorometric analysis. Blood was collected from the tail into
heparinized capillary tubes at the selected time points and diluted in PBS.
After washing, blood cells were first incubated in saturating doses of pu-
rified 2.4G2 (anti-mouse Fc receptor; ATCC) in 200l PBS–0.2% bovine
serum albumin (BSA)–0.02% NaN3 (fluorescence-activated cell sorter
[FACS] buffer) for 20min on ice to prevent antibody binding to Fc recep-
tor. Blood cells were stained on ice with various fluorescent monoclonal
antibody (MAb) combinations in FACS buffer and further collected on a
FACScalibur cytofluorimeter (Becton, Dickinson [BD]). We purchased
the following MAbs from BD Biosciences: fluorescein isothiocyanate
(FITC)-coupled 145-2C11 (anti-CD3ε), phycoerythrin (PE)-coupled
1A8 (anti-Ly-6G), and Alexa 647-coupled M5/114.15.2 (anti-major his-
tocompatibility complex class II [anti-MHC-II]).
Immunofluorescence microscopy on fixed bacteria. Blood from
ubiquitin-GFP C57BL/6 mice infected with 5 107 CFU of mCherry-Br
was diluted 1/1 (without preliminary wash or centrifugation) for 15 min
in PBS containing 4% paraformaldehyde (pH 7.4) before being smeared
on slides. The slides were dried overnight at room temperature and then
mounted in Fluoro-Gel medium containing 4=,6-diamidino-2-phenylin-
dole (DAPI) nucleic acid stain (Electron Microscopy Sciences, Hatfield,
PA). The labeled cells were visualized with an Axiovert M200 inverted
microscope (Zeiss, Iena, Germany) equipped with a high-resolution
monochrome camera (AxioCamHR;Zeiss). Images (1,384 by 1,036 pixels
[0.16m/pixel]) were acquired sequentially for each fluorochrome using
an LD-Plan-NeoFluar 63/0.75 numerical-aperture (NA) dry objective
and recorded as 8-bit gray-level zvi files. Images were exported as TIFF
files, and figures were created using Canvas 7 software.
Immunofluorescence microscopy of live bacteria. Wild-type
C57BL/6 mice were infected with 5  107 CFU of GFP- or mCherry-
expressing Brucella melitensis. Blood samples were harvested at 3 h and 24
h postinfection and immediately diluted 10 in PBS. For the observation,
the samples were directly dropped on an agarose pad (solution of 1%
agarose in PBS), covered with a coverslip, and sealed with Valap (1/3
Vaseline, 1/3 lanolin, and 1/3 paraffin wax). The sealed pad was placed at
4°C for 10min before imagingwith aNikon 80i (objective phase-contrast,
100, plan Apo) connected to a Hamamatsu Orca-Er camera in a bio-
safety level III laboratory facility.
Multispectral imaging flow cytometry (ImageStream). Events were
imaged using multispectral imaging flow cytometry (ImageStream 100;
Amnis Corp., Washington). At least 60,000 events were collected from
each sample (100,000 for blood samples), and the data were analyzed
using image analysis software (IDEAS; Amnis Corp., Washington).
Bright-field images of the cells and bacteria were recorded in channel 2,
and mCherry bacteria were recorded in channel 4. The acquisition gate
included all cells and bacteria and excluded fragments of cells and cell
aggregates. Gate R1 was based on the mCherry signal and allowed for the
identification of bacteria inside and outside blood cells. The distinction
between overlapping bacteria and extracellular (free or adherent) bacteria
wasmade by a combination of the erosionmask applied on the bright field
image and the intensity mask at 50% in the specific mCherry channel and
using the intensity feature of IDEAS software. Briefly, a bacterium was
tagged as intracellular when its fluorescent image overlapped with the
bright-field image of blood cells. The intracellular or extracellular location
of the bacteria was always confirmed by examination of the images.
Confocal microcopy. Confocal analyses were performed using the
LSM780 confocal system fitted on an Observer Z1 inverted microscope
equipped with an alpha Plan Apochromat 63/1.46 NA oil immersion
objective (Zeiss, Iena, Germany). The 488-nm excitation wavelength of
Vitry et al.
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the argon/2 laser, a main dichroic HFT 488, and a band-pass (BP) emis-
sion filter (BP 500 to 530 nm) were used for selective detection of the
enhanced GFP (eGFP) fluorochrome. The 543-nm excitation wavelength
of the HeNe1 laser, a main dichroic HFT 488/543/633, and a long-pass
emission filter (BP 580 to 650 nm) were used for selective detection of the
mCherry fluorochrome. Stacks of 1-m-thick (i.e., 1 Airy Unit for the red
fluorophore) optical sections (volume sampled, 27 by 27 by 5.2 m, 512
by 512 pixels; scaling, x and y, 0.053 m; z, 0.370 m) were collected
sequentially for each fluorochrome throughout the thickness of the object
and stored as 16-bit .lsm files. File stacks were processed for deconvolu-
tion using the Huyghens software program (Scientific Volume Imaging
BV,Hilversum, TheNetherlands), and three-dimensional (3D) rendering
was performed using Imaris software (Bitplane AG, Zurich, Switzerland).
Images were exported as 8-bit uncompressed .TIF image files.
Scanning electronmicrocopy. Samples were fixed overnight at 4°C in
4% PFA–0.1M cacodylate buffer (pH 7.2) and postfixed in OsO4 (2%) in
the same buffer. After serial dehydration, sampleswere dried to the critical
point and coated with platinum by standard procedures. Observations
were made using a Tecnai field emission gun (FEG) ESEM Quanta 200
(FEI) instrument, and images were processed by using the SIS iTEM
(Olympus) software program.
Transmission electronmicrocopy. Infected red blood cells were fixed
overnight in 2.5% glutaraldehyde in cacodylate buffer, postfixed in 2%
osmium tetroxide, serially dehydrated in ethanol, and embedded in epoxy
resin (Agar 100 resin; Agar Scientific, United Kingdom). Ultrathin 70-nm
sections were obtained, mounted on copper-Formvar-carbon grids
(EMS, United Kingdom), and stained with uranyl acetate and lead citrate
by standard procedures. Observations were made on a Tecnai 10 electron
microscope (FEI, Eindhoven, The Netherlands), and images were cap-
tured with a Veleta charge-coupled-device (CCD) camera and processed
using the AnalySIS and Adobe Photoshop software programs.
ELISA. Specific murine IgM, IgG1, IgG2a, and IgG3 isotypes were
determined by enzyme-linked immunosorbent assay (ELISA). Polysty-
rene plates (Nunc 269620) were coated with heat-killed B. melitensis (107
CFU/ml). After incubation overnight at 4°C, plates were blocked for 2 h at
RTwith 200l of PBS-3.65% casein. The plates were then incubated for 1
h at RTwith 50l of serial dilutions of the serum in PBS-3.5% casein. Sera
from naive mice were used as the negative control. After 4 washes with
PBS, isotype-specific goat anti-mouse horseradish peroxidase conjugates
were added (50 l/well) at appropriate dilutions (anti-IgM from Sigma;
LO-MG1-13 HRPO, LO-MG2a-9 HRPO, and LO-MG3-13 HRPO from
Lo-Imex). After 1 h of incubation at room temperature, the plates were
washed 4 times in PBS, and 100l/well of substrate solution (BDOptEiA)
was added to eachwell. After 10min of incubation at room temperature in
the dark, the enzyme reaction was stopped by adding 25 l/well of 2 N
H2SO4, and the absorbance was measured at 450 nm.
Statistical analysis. We used a (Wilcoxon-)Mann-Whitney test pro-
vided by theGraphPadPrism software program to statistically analyze our
results. Each group of deficient mice was compared to wild-type mice. P
values of0.05 were considered to represent a significant difference.
RESULTS
Long-term persistence of B. melitensis in the bloodstream. Bac-
teremia is common in human brucellosis (10), but reports of the
presence of Brucella in the blood of infectedmice are very rare and
old (13). In order to quantify the persistence of bacteria in the
blood of infected mice, we collected samples from wild-type
C57BL/6 mice infected with different doses (4 104, 1 106, or
5  107 CFU) of mCherry-expressing Brucella melitensis
(mCherry-Br) and determined the bacterial titers (Fig. 1A) at dif-
ferent time points postinfection (p.i.). Surprisingly, we observed
that bacteria persist for at least 2 weeks in the blood of infected
mice (Fig. 1A). When a high dose of bacteria (5 107 CFU) was
inoculated, 100% of themice (Fig. 1B) displayed amean of almost
5 103 CFU/ml of blood at 13 days p.i. Clearance of the bacteria
appeared to be dose dependent, since at amore classical dose (4
104 CFU), only 28% of the mice showed detectable blood bacte-
remia, and these displayed a mean of 102 CFU/ml of blood at 13
days p.i. (Fig. 1A and B).
In order to confirm the presence of infectious Brucella in the
blood of infected mice, naive (recipient) C57BL/6 mice were in-
FIG 1 Persistence of infectious B. melitensis in the blood of mice after i.p.
infection. (A and B) Wild-type C57BL/6 mice were injected i.p. with 4 104,
106, or 5  107 CFU of mCherry-expressing B. melitensis (mCherry-Br). and
blood was collected at selected time points. The data represent either the
means  SEM of mCherry-Br CFU per ml of blood (A) or the percentage of
mice that still had bacteria in the blood (B). The results are representative of
two independent experiments. (C)Wild-type C57BL/6 mice were injected i.p.
with 106 CFU of mCherry-Br, and blood was collected at 1 (01d), 3, 6, and 13
days p.i. Blood was immediately diluted 20 in PBS and transferred i.p. (500
l) to recipient wild-type C57BL/6 mice. Two weeks after blood transfer, the
mice were sacrificed and the spleens were harvested. The data represent
the CFU per spleen and are representative of two independent experiments.
The gray bars represent the medians.
Infection of Erythrocytes by Brucella melitensis
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jected intraperitoneally (i.p.) with fresh blood frommice infected
with 106 CFU for 1, 3, 6, and 13 days (Fig. 1C). Twoweeks later, all
recipient mice displayed CFU counts in the spleen, showing that
the blood transferred from infected mice contained living and
virulent Brucella melitensis.
Type IV secretion systemandflagella are not critically impli-
cated in blood persistence of Brucella. Several bacterial patho-
gens, such as Bartonella spp. (28), are well known to persist in the
bloodstreamduring infection. In aBartonella experimentalmouse
model, it has been demonstrated that both the type IV secretion
system (29, 30) andflagella (31, 32) are necessary for persistence in
blood. In order to test their role in Brucella persistence in the
blood, naive C57BL/6 mice were injected i.p. with 106 CFU of the
wild type, virB mutant (deficient for the type IV secretion system
[23]), or fliCmutant (deficient for flagellum expression [24]) ofB.
melitensis strain 16M. We observed that wild-type and mutant
strains displayed similar blood persistence until 3 days p.i. (Fig. 2).
We observed a lower CFU count of the VirB mutant in the blood
only at 6 and 13 days p.i. No significant differences between wild-
type and FliC mutant strains were observed at all time points
tested.
Vaccination-induced specific antibodies are able to reduce
Brucella persistence in the bloodstream. Some studies have re-
ported that natural IgM antibodies play a crucial role in the early
trapping of viral and bacterial particles. This capture reduces
pathogen dissemination and infection of organs (33, 34). In order
to determine the impact of natural antibodies on the persistence of
Brucella in blood, we compared the CFU levels of Brucella in the
blood of wild-type andMuMT/mice (B cell deficient) infected
i.p. with 5  107 CFU (Fig. 3A). Our results showed that the
complete absence of B cells and antibodies inMuMT/mice did
not affect the bacterial count in the blood between 1 and 3 days
p.i., suggesting that natural antibodies are not able to impair Bru-
cella persistence in the blood in our experimental model.
Kinetic analyses of Brucella-specific antibodies in the serum of
Brucella-infected mice showed specific IgM antibodies appearing
at 6 days, whereas IgG2 and IgG3 antibodies were detectable by 28
days p.i. (Fig. 3B). In order to test the impact of infection-induced
specific antibodies on the persistence ofBrucella in the blood,mice
immunized previously (60 days before) with live virulent bacteria
and cured of infection with antibiotics were challenged i.p. with
5  107 CFU of mCherry-Br. In agreement with findings of a
previous study (35), we observed that the persistence ofBrucella in
the blood was strongly reduced in wild-type immunized mice but
not in MuMT/ immunized mice, demonstrating that specific
FIG 2 Type IV secretion system (VirB)-deficient and flagellum (FliC)-defi-
cient strains of B. melitensis are able to persist in the blood of infected mice
until day 3. Wild-type C57BL/6 mice were injected i.p. with 106 CFU of the
wild-type (wt), FliC, or VirB strain of B. melitensis, and blood was collected at
the indicated time points. The data represent the CFU per ml of blood of
individual mice and are representative of three independent experiments. The
gray bars represent the medians. , P 0.01.
FIG 3 Natural antibodies do not prevent dissemination of B. melitensis in the
blood, whereas vaccine-induced specific antibodies reduce the bacteremia fol-
lowing a secondary infection. (A) Wild-type and MuMT/ C57BL/6 mice
were immunized i.p. with 4 104 CFU of B. melitensis (vaccinated group) or
injected i.p. with PBS (naive group) and then treated with antibiotics for 3
weeks, as described in Materials and Methods. Sixty days after immunization,
all mice were injected i.p. with 5  107 CFU of mCherry-Br, and blood was
collected at the indicated time points. The data represent the CFU per ml of
blood and are representative of three independent experiments. The gray bars
represent the medians. , P  0.001; ns, not significant. (B) Wild-type
C57BL/6 mice were infected with 4  104 CFU of B. melitensis. Serum was
collected at the indicated time points, and ELISA was performed to determine
the isotype distribution of the Brucella-specific antibodies. The data represent
the means SEM of results for 6 mice. O.D., optical density.
Vitry et al.
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antibodies are able to impair the persistence of Brucella in the
blood.
Brucella is mostly cell associated in blood. Given the strong
impact of specific antibodies on persistence of Brucella in the
blood, its long-term persistence in bloodmust mean that the bac-
teria are harbored in an intracellular location in order to escape
from circulating antibodies.
In order to determine the location of Brucella in the blood
during infection, we compared the CFU levels in the cellular frac-
tion (pellet) and plasma fraction (supernatant) obtained follow-
ing centrifugation of blood samples from mice infected with 4
104 or 106 CFU (Fig. 4A). At 3 h p.i., the bacteria were found
mainly in the plasma (70 to 75%), and only 20 to 30% of the
bacteria were found in the pellet. However, 3 days p.i., the per-
centage in the pellet increased, to reach about 50 to 80%, suggest-
ing that Brucella progressively associates with blood cells.
Brucella has beenmainly found to infectmyeloid cells in vivo in
mice (21, 36, 37). We therefore postulated that elimination of
leukocytes should result in a reduction in the level of CFU. Using
Plasmodipur filters (26, 27), we purified erythrocytes from mice
infected with 5 107 CFU at different times after infection. Flow
cytometry analysis confirmed the drastic elimination of all CD3
(T cells), Ly-6G (neutrophils), andMHC-II (monocytes and B
cells) leukocytes after filtration (Fig. 4B). Surprisingly, total blood
cells and purified erythrocytes displayed similar CFU levels at all
times tested (Fig. 4C), suggesting that bacteria are associated with
the erythrocyte-enriched fraction rather than with leukocytes. In
order to test the ability of erythrocytes to transfer brucellosis, na-
ive C57BL/6 mice were injected i.p. with purified erythrocytes
from 3-day 5  107 CFU-infected mice. Two weeks later, all i.p.
injectedmice displayed CFU counts in the spleen, confirming that
purified erythrocytes are able to transfer infectious B. melitensis in
mice (data not shown).
Brucella associates preferentiallywith erythrocytes in blood.
In order to clearly establish the location of Brucella in blood dur-
ing infection, we performed fluorescence microscopic analyses of
blood samples from infected mice. mCherry-expressing Brucella
(mCherry-Br) (5  107 CFU) was injected i.p. into transgenic
C57BL/6 mice expressing GFP under the control of the ubiquitin
promoter (17), and bloodwas collected at 3 and 24 h p.i. Note that
the collected blood was immediately diluted in paraformaldehyde
(PFA) for fixation without centrifugation or staining in order to
avoid artifacts. Thirty minutes after fixation, blood was smeared
on slides and air dried overnight, and DAPI staining was per-
formed with mounting medium.
Interestingly, whatever the time point tested, microscopic ob-
servations never showed the binding of Brucella to nucleated
(DAPI) cells. In agreement with results shown in Fig. 4C, Bru-
cella was found either free or in close association with the eryth-
rocytes at 3 h p.i. (35 free and 45 associated out of 80 bacteria
observed). At 24 h, Brucella was mainly found associated with the
erythrocytes (8 free and 52 associated out of 60 bacteria observed;
several examples of association are shown in Fig. 5A). These ob-
servations were confirmed in the absence of fixation and mount-
ing mediumwith mCherry-Br (Fig. 5B) and GFP-expressing Bru-
cella (GFP-Br) (Fig. 5C).
In order to more rigorously and more easily determine the
location of Brucella in the blood, we performed a multispectral
imaging flow cytometry (ImageStream) analysis (Fig. 6) of blood
samples from wild-type-infected mice. This technique allowed us
to analyze 100,000 cellular events per blood sample. Note that, as
previously, blood was immediately diluted in PFA for fixation
without centrifugation to avoid cell lysis or infection.
In a preliminary experiment, we confirmed that ImageStream
analysis was able to detectmCherry-Br fluorescence in blood sam-
ples from infected mice (Fig. 6A). We also tested whether Image-
Stream is able to discriminate, based on morphological and fluo-
rescent parameters, between free and adherent extracellular
mCherry-Br blood cells and between uninfected and infected
FIG 4 Blood location of B. melitensis after i.p. infection. (A) Wild-type
C57BL/6 mice were injected i.p. with 4 104 or 106 CFU of mCherry-Br, and
blood was collected at the indicated time points. Samples were diluted and
centrifuged to separate blood cells from plasma. The data represent the
mean SD of the percentage of CFU in each blood fraction and are represen-
tative of two independent experiments. (B and C) Wild-type C57BL/6 mice
were injected i.p. with 5 107 CFU ofmCherry-Br, and blood was collected at
the indicated time points. Samples were diluted and immediately filtered with
Plasmodipur filters. (B) Total blood cells and purified erythrocytes were ana-
lyzed by flow cytometry using anti-CD3ε, anti-Ly-6G, and anti-MHC-II anti-
bodies in order to confirm the elimination of all leukocytes. (C) The data
represent the CFU per ml of total blood or purified erythrocytes and are rep-
resentative of two independent experiments with 3 mice per group.
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RAW cells (Fig. 6B). In these experiments, uninfected RAW cells
and RAW cells infected in vitro with mCherry-Br were used as
internal controls to demonstrate that we are able to visualize Bru-
cella inside phagocytic nucleated cells.
Unfortunately, we observed that the low fluorescence of
mCherry-Br does not allow us to perform cell surface staining
(data not shown). Consequently, cells were identified based only
on morphological aspects, but, as illustrated in Fig. 6B, white and
FIG 5 Immunofluorescencemicroscopy of fixed or live bacteria. (A) Ubiquitin-GFP C57BL/6mice were infected i.p. with 5 107 CFU ofmCherry-Br and bled
at 3 h and 24 h p.i. The blood was fixed and then smeared on slides. The slides were dried overnight and then mounted in Fluoro-Gel medium containing DAPI
nucleic acid stain (ElectronMicroscopy Sciences, Hatfield, PA) and examined under a fluorescence microscope. Brucellawas found associated with erythrocytes
mainly at 24 h, and thuswe present only images starting at 24 h p.i. The figure shows examples ofmCherry bacteria associatedwithDAPI- erythrocytes. The panels
are color coded according to the antigen examined. Scale bar 20 or 10m, as indicated. The data are representative of at least 3 independent experiments with
a total ofmore 200 bacteria observed. (B andC)Wild-type C57BL/6mice were infected with 5 107 CFU ofmCherry-Br (B) or GFP-Br (C). Blood samples were
harvested at 3 h and 24 h p.i. and immediately diluted 10 in PBS. Freshly harvested blood samples were directly dropped on an agarose pad and sealed with
VALAP before observation under a fluorescence microscope in a biosafety level III laboratory facility. The data are representative of at least 3 independent
experiments, with a total of more than 30 bacteria observed under each condition.
Vitry et al.
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FIG 6 ImageStream analysis of blood from infectedmice.Wild-type C57BL/6mice were injected i.p. with 5 107 CFU of mCherry-Br, and blood was collected
at 3 h, 24 h, and 72 h p.i. The blood samples were immediately fixed by 3-fold dilution in 4% paraformaldehyde and then analyzed bymultispectral imaging flow
cytometry (ImageStream 100). As controls, we used a fresh culture of wild-type Brucella, mCherry-Br, and amacrophage cell line (RAW cells) at 3 h post-in vitro
infection with mCherry-Br. (A) Comparison of the percentage of events displaying a positive mCherry (channel 4) fluorescent signal (gate R1) in blood from
control and infected mice. (B) Representative images of free bacteria and uninfected and infected cells in channels 2 and 4. (C and D) Kinetic analysis of the
percentages of free or adherent bacteria (in blue) and bacteria overlapping with cells (in green) found in blood samples from control and infected mice. The
location of bacteria was defined by erosion mask. These data are representative of three independent experiments.
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red blood cells are easily distinguishable. We classified Brucella as
“free,” “adherent,” or “overlapping with a cell” using a combina-
tion of the erosionmask applied on the bright-field image and the
intensity mask in the specific mCherry channel (seeMaterials and
Methods). Examples of “free,” “adherent,” and “overlapping with
a cell” Brucella are showed in Fig. 6B.
Kinetic ImageStream analysis of infected blood (Fig. 6C)
showed that some bacteria were found extracellularly (free or ad-
hering to cells) at 3 and 24 h p.i. (0.05% of the total acquired
events) but not at 72 h p.i. In contrast, the percentage of bacteria
found that overlapped with erythrocytes increased exponentially
until 72 h p.i. (up to 1.5% of the total acquired events). Indepen-
dently of the time point tested, we never observed binding or
overlapping of Brucella with white blood cells or several bacteria
inside erythrocytes.
In summary, ImageStream analysis showed that following a
brief free extracellular stage, Brucella rapidly associated with
erythrocytes. At 3 h p.i., 67% of the Brucella events were already
identified as “Brucella overlapping with erythrocytes” (Fig. 6D).
At 24 h and 72 h p.i., this percentage peaked at 80 and 100%,
respectively (Fig. 6D).
We have carefully examined the possibility that phagocytosis
causes alteration of themCherry signal and therefore hampers the
detection of mCherry-Br in phagocytic cells, such as neutrophils
and monocytes. In our experimental model, ImageStream was
able to detect mCherry-Br inside infected RAW macrophages. A
previous study by our group demonstrated that mCherry-Br was
also detectable inside inducible nitric oxide synthase (iNOS)-ex-
pressing inflammatory dendritic cells in situ and that themCherry
signal is well correlated with the detection of Brucella antigen by
antibodies (21). Together, these data strongly suggest that our
experimental procedures allow us to detect mCherry-Br-infected
phagocytic cells in the bloodstream.However, we cannot formally
exclude the possibility that phagocytic cells represent a minor
fraction of infected cells in the bloodstream.
Fluorescent and electron microscopic analysis demon-
strated the in vivo invasion of erythrocytes by Brucella. Image-
Stream analysis allowed us to visualize a great number of blood
cells, but the image resolution was poor and the images of bacteria
overlapping with erythrocytes did not formally prove the intracel-
lular location of Brucella inside erythrocytes.
In order to investigate this point, we performed scanning elec-
tron microscopic and confocal microscopic analyses of blood
samples from infected mice.
Scanning electron microscopy of blood from 24 h infected
mice (Fig. 7A) showed that Brucella was either found free in the
blood (a) or adherent to erythrocytes (b). We also observed de-
formed erythrocytes (Fig. 7A, c and d), suggesting the presence of
Brucella inside the erythrocytes. Using confocal microscopy, we
analyzed blood samples from 24-h-mCherry-Br-infected ubiqui-
tin-GFP mice. A Z-stack analysis was performed on erythrocytes
presenting adherentmCherry-Br or a clear overlapwithmCherry-
FIG 7 Brucella is found associated with or inside erythrocytes by scanning electron and confocal microscopy. (A) Scanning electron microscopy images from
blood collected in mice 3 h p.i. by i.p. injection of 5 107 CFU of Brucella. Extracellular bacteria (a), attachment of Brucella to erythrocytes (b), and deformed
erythrocytes, suggesting Brucella infection (c and d), are shown. (B) Confocal microscopy images of blood collected in mice 24 h p.i. by i.p. injection of 5 107
CFU of Brucella. Attachment of Brucella to erythrocytes (a) and Brucella inside erythrocytes (b) are shown.
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Br. These images were processed for 3D reconstruction using the
Imaris program (Fig. 7B). We confirmed by this technique that in
all cases (n  10) of clear overlap selected, bacteria were found
inside the erythrocytes.
Brucella is known to cause extramedullary hematopoiesis (38),
resulting in the appearance of large numbers of immature blood
cells in the spleen. In order to exclude all doubts regarding the
capacity of Brucella to infect mature erythrocytes in vivo and to
gain more information on the mechanism(s) of invasion, we per-
formed transmission electron microscopic (TEM) analyses of
blood cells from 24-h-infected mice. The images (Fig. 8A) con-
firmed that the infected blood cells were mature erythrocytes,
since all infected cells observed (n  16) never displayed nuclei
and organelles. Intraerythrocytic Brucella did not appear sur-
rounded by a vacuole (Fig. 8B and C), suggesting that these bac-
teria were free in the cytoplasm of the erythrocytes.
DISCUSSION
We used ImageStream analysis, confocal microscopy, and elec-
tronmicroscopy to provide the first demonstration of erythrocyte
invasion during the persistence of B. melitensis in the bloodstream
following intraperitoneal infection.
In vitro studies have shown that Brucella can invade and repli-
cate in a range of nonphagocytic cells (trophoblasts, epithelial
cells, and fibroblasts) (39–42). However, until now, the virulence
ofBrucella in vivohas been associated onlywith its ability to invade
and replicate in phagocytic cells, such as macrophages and den-
dritic cells (21, 36, 37). To our knowledge, our results establish for
the first time the persistence of Brucella within erythrocytes of
infected mice. Surprisingly, during our study, we never observed
the association of Brucella with phagocytic white blood cells, and
depletion of leukocytes using Plasmodipur filters did not reduce
the ability of blood from infected mice to transfer infection in
naive mice. Our internal control, RAW infected cells, suggested
that phagocytosis did not impair the detection of mCherry under
our experimental conditions. In addition, a previous study
showed that mCherry-Br can be detected in vivo in activated
iNOS macrophages and inflammatory dendritic cells (21). A
study by Braude et al. dating from 1951 (13) reported the phago-
cytosis of Brucella abortus by polymorphonuclear leukocytes in
the blood of mice 3 h after the intraperitoneal inoculation of 1012
CFU. However, this observation may have been an artifact due to
the injection of a very high dose of bacteria, 1,000-fold superior to
the 109-CFU lethal dose inmice. In conclusion, our study does not
exclude that white blood cells could be infected during the course
of infection by Brucella melitensis but strongly suggests that in the
model used, erythrocytes are the cells most frequently infected in
the blood.
Gentamicin treatment is frequently used to discriminate be-
tween intra- and extracellular bacterium location. We have per-
formed a brief (1 h, 4°C) gentamicin treatment at different con-
centrations with free bacteria and blood samples from mice
infected for 3 or 72 h. Note that the samples were immediately
plated after treatment without centrifugation to avoid erythrocyte
lysis. Our data showed that bacteria in the “72 h blood” group are
more resistant than either free bacteria or bacteria from “3 h
blood” groups for all gentamicin concentrations tested. We ob-
served that 	50% of the bacteria in the “72 h blood” group sur-
vived to the treatment with 200 g/ml of gentamicin. In contrast,
only around 10% resisted in other groups (data not shown). Gen-
FIG 8 Brucella is not surrounded by a vacuole in erythrocytes. Transmission electron microscopy analysis of erythrocytes frommice 24 h post-infection by i.p.
injection of 5 107 CFU of Brucella.
Infection of Erythrocytes by Brucella melitensis
September 2014 Volume 82 Number 9 iai.asm.org 3935
 o
n
 August 12, 2014 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
tamicin is generally presented as an antibiotic that acts only on
extracellular bacteria, but this is an oversimplification. Several
studies have demonstrated that gentamicin can kill intracellular
bacteria inside macrophages (43). In addition, pharmacokinetic
studies have shown that gentamicin slowly penetrates human
erythrocytes (44). We suspect that infected erythrocytes may be
more fragile and susceptible to being lysed during in vitro incuba-
tion. This can explain why bacteria, even when located inside
erythrocytes, remain partially sensitive to gentamicin in our
model.
In the model of erythrocyte infection by Bartonella spp., per-
sistence in blood and erythrocyte invasion have been reported to
be drastically reduced in the absence of a functional type IV secre-
tion system (29, 30) or flagella (31, 32). In our Brucella model of
infection, a bacterial strain deficient for flagella (FliCmutant) was
able to persist in the blood at a level that was similar to that of the
wild-type strain, thus demonstrating that flagella are not impli-
cated in blood persistence and presumably in erythrocyte inva-
sion. Deficiency for the type IV secretion system (VirB mutant)
did not affect early persistence of bacteria in the blood.Only blood
CFU levels appeared to be reduced by 1 log at a later time point.
Since persistence of the VirB mutant in the spleen is known to be
reduced at a later time point (23; data not shown), we can only
conclude that the type IV secretion system is not critically impli-
cated in blood persistence, since this strain remains able to persist
until 13 days p.i., in contrast to the complete inability ofBartonella
type IV secretion system mutants to cause bacteremia (29).
We also investigated whether the control of B. melitensis per-
sistence in the blood involves circulating antibodies and B cells.
Some studies have reported that natural antibodies play an impor-
tant protective function in the control of early dissemination of
viruses (vesicular stomatitis virus, vaccinia virus, and lymphocytic
choriomeningitis virus) and facultative intracellular bacteria (Lis-
teria monocytogenes) (33, 34). Natural antibodies could increase
the early trapping of pathogens in secondary lymphoid organs by
enhancing phagocytosis. Previously, several groups have analyzed
the role of natural antibodies in an experimental model of Bru-
cella, with contradictory results. Natural antibodies have been re-
ported to promote the control of an attenuatedBrucellamutant by
facilitating its elimination by phagocytosis (45). Many serum
transfer experiments have demonstrated that antibodies play a
positive role in protectingmice against Brucella infection (46–48).
In this study, we were unable to detect Brucella-specific antibodies
in naivemice or during the 3 first days p.i. Specific IgM antibodies
were first detected at 6 days and IgG antibodies at 28 days, with a
predominance of the IgG2a and IgG3 isotypes. This observation
and the fact that the numbers of bacteria found in the bloodstream
during infection appear to be similar in wild-type andMuMT/
mice demonstrated that natural antibodies had no or only aminor
impact onBrucella trapping in naivemice under our experimental
conditions. In contrast, we observed that specific circulating anti-
bodies present in vaccinated wild-type mice dramatically reduced
the bacterial count persisting in the blood after a secondary infec-
tion. This suggests that the blockage of Brucella erythrocyte colo-
nization could constitute an important step in the protective im-
mune response against Brucella infection.
Although erythrocytes do not appear to constitute a replication
niche for Brucella, since each infected cell contained only a single
bacterium, they could serve as an important part of the pathogen
reservoir. Given the long life-span of erythrocytes (49), Brucella
could potentially persist hidden in this environment for several
months. The undulating fever characteristic of human brucellosis
and the high risk of relapse also argue for regularly occurring new
bacteremia waves. In this context, the failure to replicate within
erythrocytes could be advantageous for Brucella.
Of course, our data were obtained using the murine experi-
mental model of infection with Brucella melitensis, and their rele-
vance to other Brucella species and in the natural host remains to
be demonstrated. However, bacteremia is common in human
brucellosis (11), and an in vitro study has reported that Brucella is
able to bind to sialic acid residues on human erythrocytes (50),
suggesting that erythrocyte invasion could also occur in patients.
From an evolutionary point of view, the unexpected ability of
Brucella to infect erythrocytes is not so surprising. Indeed, several
bacterial pathogens belonging to the Alphaproteobacteria (Barto-
nella spp. [28] andAnaplasmamarginale [51]) andGammaproteo-
bacteria (Francisella tularensis [52, 53]) phyla persist inside eryth-
rocytes in the bloodstreamduring infection and are transmitted to
the host by ticks or fleas. Numerous old studies (5, 54–57) and a
study published in 2013 (58) have documented the presence of
Brucella in bloodsucking arthropods (ticks and fleas) under natu-
ral conditions. These observations, combined with our demon-
stration of the ability of B. melitensis to infect erythrocytes in vivo,
render plausible the hypothesis that under natural conditions,
erythrocytes could constitute an alternative reservoir for Brucella
and thatBrucella could be transmitted to the host by bloodsucking
arthropods. We hope that this hypothesis will be investigated in
the future.
In conclusion, invasion of erythrocytes could constitute a cru-
cial unexpected step that promotes the evasion of host immune
defenses. This new trait of Brucella pathogenesis opens up new
areas of research. Since erythrocytes are not capable of endocytosis
(59), wewill nowneed to define the precisemechanismofBrucella
uptake by the cell and identify the virulence factors necessary for
this process. We have tested several in vitro protocols to infect
erythrocytes from naive mice. Unfortunately, under conditions
where RAW cells were fully infected, we never observed erythro-
cyte infection (data not shown). In addition, it would be interest-
ing to investigate the homing of infected erythrocytes in tissues
and whether they trigger a different immune response than other
infected cells.We are thus left with the exciting challenge of deter-
mining the importance of this mechanism to pathogenesis and
transmission of the infection.
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